|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
5
|
|
pubmed:dateCreated |
1993-1-28
|
|
pubmed:abstractText |
(a) To develop an assay for streptokinase resistance. (b) To determine the prevalence of streptokinase resistance in patients presenting with acute myocardial infarction for the first time. (c) To determine the prevalence of streptokinase resistance in patients after exposure to streptokinase or streptococcal infection.
|
|
pubmed:commentsCorrections |
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
AIM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Nov
|
|
pubmed:issn |
0007-0769
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
68
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
449-53
|
|
pubmed:dateRevised |
2010-9-7
|
|
pubmed:meshHeading |
pubmed-meshheading:1467027-Antibodies,
pubmed-meshheading:1467027-Drug Resistance,
pubmed-meshheading:1467027-Enzyme-Linked Immunosorbent Assay,
pubmed-meshheading:1467027-Fibrinolysis,
pubmed-meshheading:1467027-Humans,
pubmed-meshheading:1467027-Immunoglobulin G,
pubmed-meshheading:1467027-Myocardial Infarction,
pubmed-meshheading:1467027-Neutralization Tests,
pubmed-meshheading:1467027-Prevalence,
pubmed-meshheading:1467027-Prospective Studies,
pubmed-meshheading:1467027-Streptococcal Infections,
pubmed-meshheading:1467027-Streptokinase,
pubmed-meshheading:1467027-Thrombolytic Therapy,
pubmed-meshheading:1467027-Time Factors
|
|
pubmed:year |
1992
|
|
pubmed:articleTitle |
Streptokinase resistance: when might streptokinase administration be ineffective?
|
|
pubmed:affiliation |
Clinical Pharmacology Unit, School of Clinical Medicine, University of Cambridge.
|
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|
